Issues
-
Cover Image
Cover Image
β-endorphin (bEP) neuron activation prevents the growth and metastasis of mammary tumor cells by altering autonomic nervous system activities that enhance innate immune functions. Sarkar and colleagues identified the mechanism by which bEP cell transplantation into the brain prevents mammary carcinogenesis by showing that the transplants' antimetastatic effect, along with stimulation of cytotoxic function of immune cells and production of anti-inflammatory cytokines, is reversed by the treatment with an opiate antagonist, naloxone (NAL), to block bEP, the β-receptor agonist metaproterenol (MET) to activate sympathetic neurotransmission, or the nicotine acetylcholine receptor antagonist methyllycaconitine (MLA) to prevent parasympathetic neurotransmission. For details, see the article by Sarkar and colleagues on page 6282 of this issue. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
Review
Meeting Reports
Priority Reports
Effects of Photoacoustic Imaging and Photothermal Ablation Therapy Mediated by Targeted Hollow Gold Nanospheres in an Orthotopic Mouse Xenograft Model of Glioma
Microenvironment and Immunology
Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
Molecular and Cellular Pathobiology
Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment
miR-375 Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer
Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function
Prevention and Epidemiology
Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer
Therapeutics, Targets, and Chemical Biology
EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks
Tumor and Stem Cell Biology
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.